David F L Liew1,2,3, Jonathan Dau4, Philip C Robinson5,6. 1. Department of Medicine, University of Melbourne, Parkville, Victoria, Australia. 2. Department of Rheumatology, Austin Health, Heidelberg, Victoria, Australia. 3. Department of Clinical Pharmacology and Therapeutics, Austin Health, Heidelberg, Victoria, Australia. 4. Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA, USA. 5. Faculty of Medicine, University of Queensland School of Clinical Medicine, Herston, Queensland, 4006, Australia. philip.robinson@uq.edu.au. 6. Department of Rheumatology, Royal Brisbane & Women's Hospital, Metro North Hospital & Health Service, Bowen Bridge Road, Herston, Queensland, 4006, Australia. philip.robinson@uq.edu.au.
Abstract
PURPOSE OF REVIEW: This review examines axial spondyloarthritis (axSpA) and the wider field of rheumatology through a value-based healthcare (VBHC) lens. VBHC is focused on ensuring patients receive high quality care to improve outcomes and reduce unnecessary costs. RECENT FINDINGS: There are many opportunities to apply the principles of VBHC in axSpA. These include the appropriate utilization of diagnostic investigations, such as HLA-B27 and magnetic resonance imaging, assessing outcomes meaningful to patients, and optimizing care pathways. Multidisciplinary care may improve value, and reduced specialist review and medication tapering may be appropriate. Increasing the value of the care we provide to patients can occur across domains and directly and indirectly improves patient outcomes. Taking the time to integrate principles of VBHC into our practice will allow us to justifiably gain and maintain access to diagnostic and therapeutic advances for the benefit of all our patients.
PURPOSE OF REVIEW: This review examines axial spondyloarthritis (axSpA) and the wider field of rheumatology through a value-based healthcare (VBHC) lens. VBHC is focused on ensuring patients receive high quality care to improve outcomes and reduce unnecessary costs. RECENT FINDINGS: There are many opportunities to apply the principles of VBHC in axSpA. These include the appropriate utilization of diagnostic investigations, such as HLA-B27 and magnetic resonance imaging, assessing outcomes meaningful to patients, and optimizing care pathways. Multidisciplinary care may improve value, and reduced specialist review and medication tapering may be appropriate. Increasing the value of the care we provide to patients can occur across domains and directly and indirectly improves patient outcomes. Taking the time to integrate principles of VBHC into our practice will allow us to justifiably gain and maintain access to diagnostic and therapeutic advances for the benefit of all our patients.
Authors: Gothic P Thomas; Dana Willner; Philip C Robinson; Adrian Cortes; Ran Duan; Martin Rudwaleit; Nurullah Akkoc; Jurgen Braun; Chung-Tei Chou; Walter P Maksymowych; Salih Ozgocmen; Euthalia Roussou; Joachim Sieper; Rafael Valle-Oñate; Desiree van der Heijde; James Wei; Paul Leo; Matthew A Brown Journal: Clin Exp Rheumatol Date: 2016-10-07 Impact factor: 4.473
Authors: Mary-Ellen Costello; Francesco Ciccia; Dana Willner; Nicole Warrington; Philip C Robinson; Brooke Gardiner; Mhairi Marshall; Tony J Kenna; Giovanni Triolo; Matthew A Brown Journal: Arthritis Rheumatol Date: 2015-03 Impact factor: 10.995
Authors: Mary-Ellen Costello; Philip C Robinson; Helen Benham; Matthew A Brown Journal: Best Pract Res Clin Rheumatol Date: 2015-08-17 Impact factor: 4.098
Authors: James J Tsakas; David F L Liew; Cameron L Adams; Catherine L Hill; Susanna Proudman; Samuel Whittle; Rachelle Buchbinder; Philip C Robinson Journal: BMC Rheumatol Date: 2022-10-17